SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-011319
Filing Date
2019-04-11
Accepted
2019-04-11 08:30:46
Documents
6
Period of Report
2019-04-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20190410.htm 8-K 40768
2 EX-5.1 life-ex51_8.htm EX-5.1 11048
3 EX-10.1 life-ex101_42.htm EX-10.1 106060
4 EX-99.1 life-ex991_7.htm EX-99.1 12734
5 GRAPHIC gerhadlowz1v000001.jpg GRAPHIC 17344
6 GRAPHIC gwm5vqov3ren000001.jpg GRAPHIC 25874
  Complete submission text file 0001564590-19-011319.txt   231594
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 19742902
SIC: 2836 Biological Products, (No Diagnostic Substances)